EXAS
Exact Sciences Corp
Price:  
42.75 
USD
Volume:  
2,560,451.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EXAS Relative Valuation

-202.2%
Upside

As of 2024-06-14, the Relative Valuation of Exact Sciences Corp (EXAS) is (43.67) USD. This relative valuation is based on P/E multiples. With the latest stock price at 42.75 USD, the upside of Exact Sciences Corp based on Relative Valuation is -202.2%.

The range of the Relative Valuation is (43.68) - (51.15) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 33.6x - 50.4x 37.1x
Forward P/E multiples 28.4x - 39.3x 30.0x
Fair Price (43.68) - (51.15) (43.67)
Upside -202.2% - -219.7% -202.2%
42.75 USD
Stock Price
(43.67) USD
Fair Price

EXAS Relative Valuation - Historical P/E Data

Date P/E
2024-06-13 -32.84
2024-06-12 -32.37
2024-06-11 -32.37
2024-06-10 -32.95
2024-06-07 -32.98
2024-06-06 -34.32
2024-06-05 -34.99
2024-06-04 -33.38
2024-06-03 -34.43
2024-05-31 -34.92
2024-05-30 -34.76
2024-05-29 -34.43
2024-05-28 -36.12
2024-05-24 -38.29
2024-05-23 -41.55
2024-05-22 -41.09
2024-05-21 -41.12
2024-05-20 -39.18
2024-05-17 -38.70
2024-05-16 -39.91
2024-05-15 -40.98
2024-05-14 -41.49
2024-05-13 -42.71
2024-05-10 -41.11
2024-05-09 -41.60
2024-05-08 -45.70
2024-05-07 -47.18
2024-05-06 -48.67
2024-05-03 -47.69
2024-05-02 -46.51
2024-05-01 -46.10
2024-04-30 -45.60
2024-04-29 -45.16
2024-04-26 -45.21
2024-04-25 -45.17
2024-04-24 -48.58
2024-04-23 -48.81
2024-04-22 -47.95
2024-04-19 -46.83
2024-04-18 -48.77
2024-04-17 -48.57
2024-04-16 -49.06
2024-04-15 -50.21
2024-04-12 -54.81
2024-04-11 -56.04
2024-04-10 -56.54
2024-04-09 -57.05
2024-04-08 -54.80
2024-04-05 -53.95
2024-04-04 -53.90